Mark is currently Head of the School of Health Sciences and Professor of Pharmacy at the University of Canberra and teaches primarily in therapeutics and pharmacy practice. His career includes: academic, community pharmacy, hospital pharmacy, and accredited pharmacist in Tasmania, Northern Territory, and the ACT. Mark has a wide-reaching interest in the pharmacy profession and has worked internationally as a post-doctoral fellow at the University of Groningen in the Netherlands. He is credentialed to undertake medication reviews and occasionally practice in community pharmacy.
Mark’s recent research has focused on expanding the scope of practice of pharmacists and has supervised several PhD candidates in two relevant areas: evaluating the impact of pharmacists working in general practice and RACFs.
He has served on the Tasmanian PSA Branch committee (2000-2001) and the South Australian/Northern Territory PSA Branch committee (2008-2010).
Mark has been on the PSA ACT branch committee since 2017 and served on the PSA National Board since 2022 and graduated from the Australian Institute of Company Directors in 2022.
Mark has been a PSA member for 20 years and an active member of the pharmacy profession for over 25 years. He undertook one of the first clinical trials in Australia evaluating the benefits of HMRs post-discharge. He has also been involved in various evaluations of community pharmacist screening (osteoporosis) and disease management (cardiovascular disease. Mark is passionate about medication safety and firmly believes pharmacists are the most suited professional to ensure this occurs.